gemcitabine hydrochloride (Gland Pharma Limited)
Welcome to the PulseAid listing for the gemcitabine hydrochloride drug offered from Gland Pharma Limited. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gland Pharma Limited |
NON-PROPRIETARY NAME: | gemcitabine hydrochloride |
SUBSTANCE NAME: | GEMCITABINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-02-01 |
END MARKETING DATE: | 0000-00-00 |
gemcitabine hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | gemcitabine hydrochloride from Gland Pharma Limited |
LABELER NAME: | Gland Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/5mL) |
START MARKETING DATE: | 2016-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68083-148_1eb501b1-e828-4d37-95bc-88a4cea3a606 |
PRODUCT NDC: | 68083-148 |
APPLICATION NUMBER: | ANDA204520 |
Other GEMCITABINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: